恆指跌幅擴至逾600點 金融、新經濟及醫藥股領跌 阿里巴巴屢尋底
阿思達克 10-04 10:08
美國經濟數據普遍勝預期，加上藍籌藥廠默克(MRK.US)公布其研發新冠口服藥Molnupiravir能使確診者的住院和死亡率減半，並將向美國等其他國家申請緊急授權使用，股價急漲8.4%，其餘藍籌也普遍造好，經濟敏感股升幅居前，旅遊相關股受捧，帶動道指及標普分別由約三個半月及逾兩個月低位反彈回升1.4%及1.2%，前者收34,326，未能完全收復上周四急吐1.6%失地。美股期貨全面反覆回軟，道指期貨沽壓較大報34,092，回吐75點或0.2%。亞太區股市個別發展，星洲股市回升1.2%報3,086；澳洲200反彈0.9%曾高見7,305。相反，日經及台灣加權指數繼上周五急挫逾2%，今早曾分別反彈1%及0.6%，高見29,046及16,680無以為繼，掉頭倒跌1.1%及0.5%，分別報28,454及16,486。
本港8月零售銷售額按年升幅再度擴至11.9%(前值僅升2.9%)，優於市場預期，主要受惠於政府派發消費券推動。恆指繼9月累挫1,303點或5%及第三季累瀉逾4,252點或14.8%後，今天於長周末假後復市延續上周四回軟勢，在美團(03690.HK)、地產及金融板塊主導低開96點或0.4%報24,478，進一步失守10天線後，跌幅持續擴至662點或2.7%，報23,913，成交額268億元。
藍籌股幾乎全面向下，醫藥板塊沽壓最大，阿里健康(00241.HK)、中生(01177.HK)、石藥(01093.HK)及藥明生物(02269.HK)依次挫逾5%-7%，後者低見116.6元，失守50天線(119.96元)。
匯控(00005.HK)、建行(00939.HK)、工行(01398.HK)、國壽(02628.HK)、招行(03968.HK)及中國平安(02318.HK)跌逾1.5%-4%，後兩者最傷分別低見59.3元及50.85元。友邦(01299.HK)高開2%報91.8欠承接，掉頭倒跌2.9%報87.35元。
美團及阿里巴巴(09988.HK)分別挫4%及2.6%，前者報236.8元，後者低見138.1元屢創上市新低；騰訊(00700.HK)高開近2%報470元欠承接，曾低見454.4元，現報455.6元，倒跌1.3%。此外，信義玻璃(00868.HK)及信義光能(00968.HK)挫6.2%及4.4%，分別報21.85元及15.26元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
